Genovate Biotechnology Co Ltd (4130) — Long-term Investment Intensity

Latest as of September 2019: 28.8%

Genovate Biotechnology Co Ltd (4130) has a Long-term Investment Intensity of 28.8% as of September 2019. Long-term investments of NT$469.06 Million represent 28.8% of total assets of NT$1.63 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 4130 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

28.8%
LT Investments / Total Assets

Long-term Investments

NT$469.06 Million
TWD

Total Assets

NT$1.63 Billion
TWD

Country

Taiwan
TWO

Genovate Biotechnology Co Ltd Long-term Investment Intensity (2015–2018)

This chart shows how Genovate Biotechnology Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 28.8%, reflecting long-term investments of NT$469.06 Million against total assets of NT$1.63 Billion TWD. For the complete balance sheet picture, see 4130 total assets.

Annual Long-term Investment Intensity for Genovate Biotechnology Co Ltd (2015–2018)

The table below presents the year-by-year Long-term Investment Intensity for Genovate Biotechnology Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read total liabilities of Genovate Biotechnology Co Ltd for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (TWD) Total Assets Change (pp)
2018 33.6% NT$583.08 Million NT$1.74 Billion ▲ +6.3 pp
2017 27.2% NT$556.21 Million NT$2.04 Billion ▼ -20.5 pp
2016 47.8% NT$1.26 Billion NT$2.65 Billion ▲ +4.2 pp
2015 43.5% NT$1.10 Billion NT$2.52 Billion
pp = percentage points